Report cover image

China Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others

Publisher GlobalData
Published Aug 05, 2024
Length 70 Pages
SKU # GBDT19163714

Description

China Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others


Summary

GlobalData’s “China Interventional Cardiology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the China Interventional Cardiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloon Catheters, Structural Heart Occlusion Devices, Transcatheter Accessories

The China Interventional Cardiology Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Interventional Cardiology Market.
  • Global corporate-level profiles of key companies operating within the China Interventional Cardiology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

China Interventional Cardiology is segmented as follows -
  • Coronary Stents
  • Intravascular Ultrasound Systems (IVUS)
  • PTCA Balloon Catheters
  • Structural Heart Occlusion Devices
  • Transcatheter Accessories
Reasons to Buy

China Interventional Cardiology Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

70 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Interventional Cardiology Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Interventional Cardiology Market, China
3.1 Interventional Cardiology Market, China, Revenue ($m), 2018-2033
3.1.1 Coronary Stents Market, China, Revenue ($m), by Segment, 2018-2033
3.1.2 Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), by Segment, 2018-2033
3.1.3 PTCA Balloon Catheters Market, China, Revenue ($m), by Segment, 2018-2033
3.1.4 Structural Heart Occlusion Devices Market, China, Revenue ($m), by Segment, 2018-2033
3.1.5 Transcatheter Accessories Market, China, Revenue ($m), by Segment, 2018-2033
3.2 Interventional Cardiology Market, China, Volume (Units), 2018-2033
3.2.1 Coronary Stents Market, China, Volume (Units), by Segment, 2018-2033
3.2.2 Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), by Segment, 2018-2033
3.2.3 PTCA Balloon Catheters Market, China, Volume (Units), by Segment, 2018-2033
3.2.4 Structural Heart Occlusion Devices Market, China, Volume (Units), by Segment, 2018-2033
3.2.5 Transcatheter Accessories Market, China, Volume (Units), by Segment, 2018-2033
3.3 Interventional Cardiology Market, China, Average Price ($) , 2018-2033
3.4 Interventional Cardiology Market, China, Distribution Share by Revenue ($m), 2023
3.5 Interventional Cardiology Market, China, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in China, Interventional Cardiology Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Terumo Corp
4.3.1 Company Overview
4.4 Koninklijke Philips NV
4.4.1 Company Overview
4.5 Asahi Intecc Co Ltd
4.5.1 Company Overview
4.6 Medtronic Plc
4.6.1 Company Overview
4.7 AtriCure Inc
4.7.1 Company Overview
4.8 B. Braun Melsungen AG
4.8.1 Company Overview
4.9 Lepu Medical Technology (Beijing) Co Ltd
4.9.1 Company Overview
4.10 MicroPort Scientific Corp
4.10.1 Company Overview
4.11 Shockwave Medical Inc
4.11.1 Company Overview
4.12 W. L. Gore & Associates Inc
4.12.1 Company Overview
4.13 Teleflex Inc
4.13.1 Company Overview
4.14 Biotronik SE & Co KG
4.14.1 Company Overview
5 Interventional Cardiology Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Shenzhen Mindray Scientific Plans to Acquire 21.2% Stake in APT Medical for USD936.32 Million
6.2 Debt Offerings
6.2.1 MicroPort Scientific to Raise USD220 Million in Public Offering of 5.75% Convertible Bonds Due 2028
6.3 Venture Financing
6.3.1 Tianjin Hengyu Medical Technology Secures Venture Financing
6.3.2 Tianjin Hengyu Medical Technology (Hori Medcare, Tianjin Hori Medical) Secures Series D Funding
6.3.3 Shenyang Shenda Endoscope Raises Funds through Series C Financing
6.3.4 Shaoxing Mayo Magnetic Medical Technology Raises Funds through Series A+ Financing
6.3.5 Tianjin Hengyu Medical Technology (Hori Medcare, Tianjin Hori Medical) Secures Additional USD13.94 Million in Series C+ Funding
7 Recent Developments
7.1 Corporate Communications
7.1.1 Nov 10, 2023: Microport Appointment of Director
7.2 Financial Announcements
7.2.1 Jun 17, 2024: Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading
7.2.2 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report
7.2.3 Aug 31, 2023: Peijia Medical Announces 2023 Interim Results
7.3 Legal And Regulatory
7.3.1 Jun 20, 2023: Shenzhen Mindray Bio-Medical Electronics Receives an Additional 510(k) Clearance for M8 Elite Diagnostic Ultrasound System
7.4 Strategy And Business Planning
7.4.1 Jun 20, 2023: Shenzhen Mindray Bio-Medical Electronics Receives an Additional 510(k) Clearance for M11 Diagnostic Ultrasound System
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Interventional Cardiology Market, China, Revenue ($m), USD Constant, 2018-2033
Table 2: Coronary Stents Market, China, Revenue ($m), USD Constant, 2018-2033
Table 3: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, 2018-2033
Table 4: PTCA Balloon Catheters Market, China, Revenue ($m), USD Constant, 2018-2033
Table 5: Structural Heart Occlusion Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Table 6: Transcatheter Accessories Market, China, Revenue ($m), USD Constant, 2018-2033
Table 7: Interventional Cardiology Market, China, Volume (Units), 2018-2033
Table 8: Coronary Stents Market, China, Volume (Units), 2018-2033
Table 9: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), 2018-2033
Table 10: PTCA Balloon Catheters Market, China, Volume (Units), 2018-2033
Table 11: Structural Heart Occlusion Devices Market, China, Volume (Units), 2018-2033
Table 12: Transcatheter Accessories Market, China, Volume (Units), 2018-2033
Table 13: Interventional Cardiology Market, China, Average Price ($), 2018-2033
Table 14: Interventional Cardiology Market, China, Distribution Share by Revenue ($m), USD Constant, 2023
Table 15: Interventional Cardiology Market, China, Company Share by Revenue ($m), USD Constant, 2023
Table 16: Interventional Cardiology Market Pipeline Products
Table 17: Shenzhen Mindray Scientific Plans to Acquire 21.2% Stake in APT Medical for USD936.32 Million
Table 18: MicroPort Scientific to Raise USD220 Million in Public Offering of 5.75% Convertible Bonds Due 2028
Table 19: Tianjin Hengyu Medical Technology Secures Venture Financing
Table 20: Tianjin Hengyu Medical Technology (Hori Medcare, Tianjin Hori Medical) Secures Series D Funding
Table 21: Shenyang Shenda Endoscope Raises Funds through Series C Financing
Table 22: Shaoxing Mayo Magnetic Medical Technology Raises Funds through Series A+ Financing
Table 23: Tianjin Hengyu Medical Technology (Hori Medcare, Tianjin Hori Medical) Secures Additional USD13.94 Million in Series C+ Funding
Table 24: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country
List of Figures
Figure 1: Interventional Cardiology Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 2: Coronary Stents Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 3: Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 4: PTCA Balloon Catheters Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 5: Structural Heart Occlusion Devices Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 6: Transcatheter Accessories Market, China, Revenue ($m), USD Constant, 2018-2033
Figure 7: Interventional Cardiology Market, China, Volume (Units), 2018-2033
Figure 8: Coronary Stents Market, China, Volume (Units), 2018-2033
Figure 9: Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), 2018-2033
Figure 10: PTCA Balloon Catheters Market, China, Volume (Units), 2018-2033
Figure 11: Structural Heart Occlusion Devices Market, China, Volume (Units), 2018-2033
Figure 12: Transcatheter Accessories Market, China, Volume (Units), 2018-2033
Figure 13: Interventional Cardiology Market, China, Company Share (%) 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us